Relationship between serum concentrations of keratin-18 and apoptosis in chronic hepatitis C

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 6, 2010, Pages 897-899

  Gonzalez Quintela, Arturo ^a   Abdulkader, Ihab ^b   Otero, Esteban ^a   Freire, Maria Aurora ^a   Tomé, Santiago ^a  

^a University Hospital of Santiago de Compostela   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKERATIN 18;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APOPTOSIS; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LETTER; LIVER CELL DAMAGE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM;

ADULT; AGED; ANTIBODIES, MONOCLONAL; APOPTOSIS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; KERATIN-18; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RNA, VIRAL; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 77953182674     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.163     Document Type: Letter

References (11)

1. Bantel H, Schulze-Osthoff K. Apoptosis in hepatitis C virus infection. Cell Death Differ 2003;10(Suppl 1):S48-58.
2. Sheard MA, Vojtesek B, Simickova M, Valik D. Release of cytokeratin- 18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis. J Cell Biochem 2002; 85:670-677
3. Einarsson R, Rydlander L. Tissue polypeptide specific antigen (TPS) detects a specific epitope structure on human cytokeratin. Anticancer Res 1997;17:3121-3124
4. Gonzalez-Quintela A, Mallo N, Mella C, Campos J, Perez LF, Lopez-Rodriguez R, et al. Serum levels of cytokeratin-18 (tissue polypeptide-specific antigen) in liver diseases. Liver Int 2006;26: 1217-1224 (Pubitemid 44741209)
5. Tarantino G, Conca P, Coppola A, Vecchione R, Di Minno G. Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis. Eur J Clin Invest 2007;37:48-53.
6. Tarantino G, Mazzarella C, Tarantino M, Di Minno MN, Conca P. Could high levels of tissue polypeptide specific antigen, a marker of apoptosis detected in non-alcoholic steatohepatitis, improve after weight loss? Dis Markers 2009;26:55-63.
7. Gonzalez-Quintela A, Mella C, Perez LF, Abdulkader I, Caparrini AM, Lojo S. Increased serum TPS (tissue polypeptide specific antigen) in alcoholics. A possible marker of alcoholic hepatitis. Alcohol Clin Exp Res 2000;24:1222-1226
8. Gonzalez-Quintela A, García J, Campos J, Perez LF, Alende MR, Otero E, et al. Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19. Alcohol 2006;38:45-49
9. Gonzalez-Quintela A, Abdulkader I, Campos J, Fernandez-Hernandez L, Lojo S. Serum levels of keratin-18 fragments wtissue polypeptide-specific antigen (TPS)x are correlated with hepatocyte apoptosis in alcoholic hepatitis. Dig Dis Sci 2009;54: 648-653
10. Grassi A, Susca M, Ferri S, Gabusi E, D'Errico A, Farina G, et al. Detection of M30 neoepitope as a new tool to quantify liver apoptosis. Am J Clin Pathol 2004;121:211-219
11. Bantel H, Lügering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, et al. Detection of apoptotic caspase activation in sera from patients with chronic hepatitis HCV infection is associated with fibrotic liver injury. Hepatology 2004;40: 1078-1082